Related Experiment Video

Updated: Feb 13, 2026

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

61.9K

Symptomatic central nervous system viral escape in patient on darunavir monotherapy

Sara de la Fuente Moral1, Alberto Díaz de Santiago1, Alfonso Ángel-Moreno Maroto1

  • 1Departamento de Medicina Interna, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España.

Medicina Clinica
|March 3, 2018
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Culturing Microglia from the Neonatal and Adult Central Nervous System
11:28

Culturing Microglia from the Neonatal and Adult Central Nervous System

Published on: August 9, 2013

28.9K
In vivo Optogenetic Stimulation of the Rodent Central Nervous System
09:37

In vivo Optogenetic Stimulation of the Rodent Central Nervous System

Published on: January 15, 2015

60.5K

Related Experiment Videos

Last Updated: Feb 13, 2026

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

61.9K
Culturing Microglia from the Neonatal and Adult Central Nervous System
11:28

Culturing Microglia from the Neonatal and Adult Central Nervous System

Published on: August 9, 2013

28.9K
In vivo Optogenetic Stimulation of the Rodent Central Nervous System
09:37

In vivo Optogenetic Stimulation of the Rodent Central Nervous System

Published on: January 15, 2015

60.5K

Related Concept Videos

What is a Nervous System?01:25

What is a Nervous System?

105.4K
Overview
105.4K
Escape Velocity01:26

Escape Velocity

8.5K
The escape velocity of an object is defined as the minimum initial velocity that it requires to escape the surface of another object to which it is gravitationally bound and never to return. For example, what would be the minimum velocity at which a satellite should be launched from the Earth's surface such that it just escapes the Earth's gravitational field?
To calculate the escape velocity, it is assumed that no energy is lost to any frictional forces. In practice, a satellite...
8.5K
The Parasympathetic Nervous System01:14

The Parasympathetic Nervous System

116.0K
Overview
116.0K
The Sympathetic Nervous System01:25

The Sympathetic Nervous System

104.1K
Overview
104.1K
Escape Velocities of Gases01:19

Escape Velocities of Gases

1.4K
To escape the Earth's gravity, an object near the top of the atmosphere at an altitude of 100 km must travel away from Earth at 11.1 km/s. This speed is called the escape velocity. The temperature at which gas molecules attain the rms speed, which is equal to the escape velocity, can be estimated by using the equation for the average kinetic energy of the gas molecules. According to the kinetic theory of gas, the average kinetic energy of the gas molecules is proportional to its...
1.4K
The Central Dogma01:25

The Central Dogma

140.1K
Overview
140.1K

Articles linked to this work by shared authors, journal, and citation graph.

Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

Open forum infectious diseases·2026

Safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide versus continuing dolutegravir/lamivudine in people living with HIV with neuropsychiatric comorbidities: Week 24 and 48 results from the Management of INSTI-associated Neuropsychiatric Disorders (MIND) clinical trial.

International journal of antimicrobial agents·2026

Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.

Journal of the International AIDS Society·2026

Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the relativity cohort.

AIDS (London, England)·2026

Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis.

Journal of viral hepatitis·2026

Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol.

BMJ open respiratory research·2025

Temporal trends in motor neuron disease mortality in Spain (2000-2024): Population ageing versus generational risk factors.

Medicina clinica·2026

Feasibility and characteristics of contrast-enhanced lung ultrasound in the diagnosis of pulmonary embolism in hospitalized patients.

Medicina clinica·2026

Secukinumab in moderate to severe hidradenitis suppurativa: effectiveness and safety in real-world clinical practice.

Medicina clinica·2026

Tularemia: a re-emerging zoonosis.

Medicina clinica·2026

Complex regional pain syndrome and amputation.

Medicina clinica·2026

Comparative efficacy and safety of rosuvastatin versus atorvastatin after acute ischemic stroke or transient ischemic attack: A systematic review and exploratory meta-analysis.

Medicina clinica·2026

Corticosteroid Injection Versus Surgical Decompression in Carpal Tunnel Syndrome: A Prospective Comparative Interventional Study Using Clinical, Electrophysiological, and Sonographic Outcomes.

Cureus·2026

[Neuropsychological Risk Factors for Chronic Postoperative Pain Following Abdominal Surgery].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2026

Cell-type-dependent decline of IGF1 and IGF1R in the prefrontal cortex contributes to age-related behavioral changes.

Frontiers in aging neuroscience·2026

Pre-dementia clinical trajectories associated with neuronal α-synuclein neuropathologic change: a retrospective cohort study.

Research square·2026

Non-invasive brain stimulation for cognitive impairment after traumatic brain injury: an umbrella review of systematic reviews.

Frontiers in neurology·2026

The cerebrospinal fluid-contacting nucleus CGRP-RAMP1-PKA signaling pathway mediates trigeminal neuralgia and its mechanism.

The Korean journal of pain·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us